Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement-Reference-Cited by-同舟云学术

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement

Published:2020 Issue: Volume:75 Page:
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:

Author:

Chagas Aline Lopes,da Fonseca Leonardo Gomes,Coelho Fabricio Ferreira,da Cunha Saud Lisa Rodrigues,Abadala Edson,Andraus Wellington,Fiore Lucas,Moreira Airton Mota,Menezes Marcos Roberto,Carnevale Francisco César,Tani Claudia Megumi,Alencar Regiane S.S.M,D'Albuquerque Luiz Augusto Carneiro,Herman Paulo,Carrilho Flair José

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China;Guan;N Engl J Med,2020

2. Ministério da Saúde;Boletim Coronavírus

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Outcomes of COVID-19 among patients with liver disease;World Journal of Gastroenterology;2023-02-07

3. Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country;Medicina;2022-11-22

4. Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic;Journal of Interventional Medicine;2022-11

5. A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B;Egyptian Journal of Medical Human Genetics;2022-10-20